ERDERA Clinical Trial Call 2026 – Pre-announcement

Pre-announcement describing scope, eligibility and indicative timeline for the ERDERA Clinical Trial Call 2026, expected to open on 1 July 2026.

This pre-announcement outlines the upcoming ERDERA Clinical Trial Call 2026 (ECTC), expected to open on 1 July 2026, to support multinational, GCP-compliant Phase I, Phase I/II and Phase II interventional clinical trials in rare diseases.

It summarises priority areas, eligible applicants, eligible interventions (including small molecules, ATMPs and biologics), expected eligible countries and an indicative multi-stage application process, including an information webinar on 6 July 2026 (15:00–17:00 CEST).

Acces this publication

publication

ERDERA clinical trial call

Year of publication

2026

Author

European Rare Diseases Research Alliance (ERDERA)

You might also be interested in

ERDERA 2026 Open Session

From individual cases to new treatment pathways: ERDERA Open Session focuses on ultra-rare diseases

ERDERA marked the close of its second year with an Open Session on ultra-rare diseases, bringing together European, regulatory and scientific perspectives on how innovation can reach patients.
ERDERA JTc 2027

ERDERA pre-announces 2027 Joint Transnational Call on recently identified rare diseases

The Joint Transnational Call is expected to open on 1 December 2026, with an information webinar planned for 14 December.
Training online

Information Webinar – ERDERA Joint Transnational Call 2027

December 14 @ 3:00 pm - 4:00 pm
This information webinar on the 2027 Joint Transnational Call for Proposals is scheduled for 14 December 2026.
Cover of the 16-country rare disease policy assessment, October 2026.

Reckoning With the Rare Disease Landscape. A 16 Country Policy Landscape Assessment across the Life Course.

The assessment compares diagnosis, treatment access and national governance across 16 countries, examining gaps in rare disease support throughout the life course.

ERDERA Search